Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · IEX Real-Time Price · USD
1.980
-0.010 (-0.50%)
At close: Jul 19, 2024, 4:00 PM
1.990
+0.010 (0.51%)
After-hours: Jul 20, 2024, 12:58 PM EDT
Stereotaxis Market Cap
Stereotaxis has a market cap or net worth of $163.63 million as of July 22, 2024. Its market cap has increased by 37.97% in one year.
Market Cap
163.63M
Enterprise Value
150.78M
1-Year Change
37.97%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since August 12, 2004, Stereotaxis's market cap has decreased from $183.10M to $163.63M, a decrease of -10.63%. That is a compound annual growth rate of -0.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 163.60M | 15.62% |
| Dec 29, 2023 | 141.50M | -8.65% |
| Dec 30, 2022 | 154.90M | -66.50% |
| Dec 31, 2021 | 462.40M | 23.27% |
| Dec 31, 2020 | 375.10M | 6.26% |
| Dec 31, 2019 | 353.00M | 474.92% |
| Dec 31, 2018 | 61.40M | 237.36% |
| Dec 29, 2017 | 18.20M | 28.17% |
| Dec 30, 2016 | 14.20M | -10.69% |
| Dec 31, 2015 | 15.90M | -47.52% |
| Dec 31, 2014 | 30.30M | -47.49% |
| Dec 31, 2013 | 57.70M | 215.30% |
| Dec 31, 2012 | 18.30M | -55.90% |
| Dec 30, 2011 | 41.50M | -76.45% |
| Dec 31, 2010 | 176.20M | -2.22% |
| Dec 31, 2009 | 180.20M | 19.97% |
| Dec 31, 2008 | 150.20M | -63.64% |
| Dec 31, 2007 | 413.10M | 27.11% |
| Dec 29, 2006 | 325.00M | 49.56% |
| Dec 30, 2005 | 217.30M | 991.96% |
| Dec 31, 2004 | 19.90M | -89.13% |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| INmune Bio | 168.74M |
| OrganiGram Holdings | 167.46M |
| Compugen | 167.42M |
| Skye Bioscience | 167.28M |
| Repare Therapeutics | 167.23M |
| Achieve Life Sciences | 163.46M |
| TriSalus Life Sciences | 162.45M |
| Syros Pharmaceuticals | 161.97M |